Dr Reddy's Laboratories Ltd (RDY)
74.00
+3.08
(+4.34%)
USD |
NYSE |
Apr 25, 10:08
Dr Reddy's Laboratories Cash from Operations (Quarterly): 54.44M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 54.44M |
| September 30, 2023 | 215.92M |
| June 30, 2023 | 136.94M |
| March 31, 2023 | 257.01M |
| December 31, 2022 | 277.57M |
| September 30, 2022 | 113.49M |
| June 30, 2022 | 86.26M |
| March 31, 2022 | 124.00M |
| December 31, 2021 | 230.94M |
| September 30, 2021 | 69.13M |
| June 30, 2021 | -46.75M |
| March 31, 2021 | 149.64M |
| December 31, 2020 | 59.85M |
| September 30, 2020 | 127.32M |
| June 30, 2020 | 143.24M |
| March 31, 2020 | 37.40M |
| December 31, 2019 | 100.10M |
| September 30, 2019 | 141.59M |
| June 30, 2019 | 141.13M |
| March 31, 2019 | 105.50M |
| December 31, 2018 | 223.50M |
| September 30, 2018 | 156.25M |
| June 30, 2018 | -74.92M |
| March 31, 2018 | 90.33M |
| December 31, 2017 | 115.77M |
| Date | Value |
|---|---|
| September 30, 2017 | 104.23M |
| June 30, 2017 | -30.68M |
| March 31, 2017 | 128.01M |
| December 31, 2016 | 76.84M |
| September 30, 2016 | 40.44M |
| June 30, 2016 | 75.54M |
| March 31, 2016 | 145.25M |
| December 31, 2015 | 177.33M |
| September 30, 2015 | 172.20M |
| June 30, 2015 | 135.75M |
| March 31, 2015 | 171.07M |
| December 31, 2014 | 89.78M |
| September 30, 2014 | 72.47M |
| June 30, 2014 | 76.20M |
| March 31, 2014 | 139.59M |
| December 31, 2013 | 97.67M |
| September 30, 2013 | 5.128M |
| June 30, 2013 | 80.62M |
| March 31, 2013 | 46.73M |
| December 31, 2012 | 67.59M |
| September 30, 2012 | 58.60M |
| June 30, 2012 | 72.10M |
| March 31, 2012 | 154.90M |
| December 31, 2011 | 90.55M |
| September 30, 2011 | 27.83M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-46.75M
Minimum
Jun 2021
277.57M
Maximum
Dec 2022
127.33M
Average
127.32M
Median
Sep 2020
Cash from Operations (Quarterly) Benchmarks
| Concord Medical Services Holdings Ltd | -- |
| ASLAN Pharmaceuticals Ltd | -- |
| Zai Lab Ltd | -14.92M |
| Infosys Ltd | -- |
| SS Innovations International Inc | -1.132M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -193.25M |
| Cash from Financing (Quarterly) | 64.15M |
| Free Cash Flow | 359.06M |
| Free Cash Flow Per Share (Quarterly) | -0.0286 |
| Free Cash Flow to Equity (Quarterly) | -82.15M |
| Free Cash Flow to Firm (Quarterly) | -4.762M |
| Free Cash Flow Yield | 2.91% |